Ontex disclosed that Goldman Sachs Group, Inc. crossed the 3% ownership threshold in Ontex shares on October 27, 2026, holding a combined total of 3.07% including voting rights and financial instruments. However, the next day, October 28, 2026, Goldman Sachs' combined holding fell below 3% to 2.38%. These disclosures are required under Belgian law for transparency in significant shareholdings. The brief crossing of the threshold indicates active trading or portfolio adjustments by Goldman Sachs in Ontex shares.
Regarding the Transparency Declaration Notification for Ontex, here is Pluang's market snapshot as of Nov 04, 2026 21:03 WIB: Among 63 priced Consumer Staples-sector US stocks tradable on Pluang, 51 rose and 8 fell today. Notable movers include Dollar General Corp. (DG) at USD 134.50 with a 3.05% increase, Honest Company Inc (HNST) at USD 4.48 up 2.99%, and Diageo plc (DEO) at USD 96.80 rising 2.92%.
Goldman Sachs Group, Inc. disclosed that it briefly held a combined stake exceeding 3% in Ontex Group NV shares as of October 27, 2026, with 566,115 voting rights and 1,965,157 financial instruments. However, by October 28, 2026, their combined posit...
BNP Paribas announced its monthly declaration of voting rights and shares as of October 31, 2026. The bank reported a total of 1,101,600,607 shares and an equal number of voting rights. This update is part of regulatory compliance under French commer...
Neion Bio has appointed John A. Maga, Ph.D., as Head of Biologics and CMC to lead the development of biologic medicines using its Raptor platform, which produces proteins in transgenic chicken eggs. Maga brings over 25 years of biopharmaceutical expe...
The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...
The Australia and New Zealand (ANZ) dental implants market, valued at $266 million in 2025, is projected to grow at a 5% CAGR to $393 million by 2033. Growth is driven by increasing demand for oral rehabilitation and prosthetic dentistry, especially ...
